The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with
Yu Aruga1,2, Chiaki Ikeda1, Hiromichi Matsushita1,3
1Department of Laboratory Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Insights
Detecting minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) is crucial. A novel flow cytometry method enhances MRD detection in atypical CLL by analyzing surface immunoglobulin light chain expression, achieving 10-4 sensitivity.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Minimal/measurable residual disease (MRD) detection is increasingly important in chronic lymphocytic leukemia (CLL) management.
- Flow cytometry offers cost-effective and immediate MRD assessment with sensitivities around 10-4.
- Atypical CLL immunophenotypes present challenges for MRD detection due to marker similarity with normal B cells.
Purpose of the Study:
- To develop a more sensitive method for MRD detection in atypical CLL cases.
- To improve the accuracy of identifying CLL cells during MRD assessment.
- To leverage specific cell surface marker characteristics of atypical CLL for enhanced detection.
Main Methods:
- Utilized flow cytometry for MRD detection in chronic lymphocytic leukemia.
- Focused on analyzing cell surface immunoglobulin (sIg) light chain expression, particularly kappa/lambda ratios.
- Defined tumor cell regions by identifying deviations in sIg light chain kappa/lambda ratios from a set threshold.
Main Results:
- Successfully detected atypical CLL cells at a sensitivity level of 10-4.
- The developed method effectively distinguished atypical CLL cells from normal B cells.
- The analysis of sIg light chain expression proved valuable for enhancing MRD detection sensitivity.
Conclusions:
- The proposed method enhances MRD detection sensitivity in challenging atypical CLL cases.
- Analyzing sIg light chain expression provides a reliable approach for identifying CLL cells.
- This method represents an effective assay for MRD detection in CLL, particularly for atypical subtypes.
Abstract:
In recent years, the significance of detecting minimal/measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL) has increased due to the availability of highly effective therapeutic agents. Flow cytometry provides notable cost-effectiveness and immediacy, with an expected sensitivity level of approximately 10-4. The critical aspect of MRD detection via flow cytometry lies in accurately defining the region containing tumor cells. However, a subset of CLL, known as CLL with atypical immunophenotype, exhibits a distinct cell surface marker expression pattern that can make MRD detection challenging, because these markers often resemble those of normal B cells. To enhance the sensitivity of MRD detection in such atypical cases of CLL, we have capitalized on the observation that cell surface immunoglobulin (sIg) light chains tend to be expressed at a higher level in this subtype. For every four two-dimensional plots of cell surface markers, we used a plot to evaluate the expression of sIg kappa/lambda light chains and identified regions where the kappa/lambda ratio of sIg light chains deviated from a designated threshold within the putative CLL cell region. Using this method, we could detect atypical CLL cells at a level of 10-4. We propose this method as an effective MRD assay.
